Ground News

News from TBNweekly

See all of TBNweekly news coverage in one place. Discover how TBNweekly’s media bias informs their coverage and compare with thousands of other news outlets.

Overall, we’ve indexed 940 stories from TBNweekly over the past 3 months.

Ground News rates TBNweekly’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

TBNweekly’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about TBNweekly

Where is TBNweekly located?TBNweekly's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top TBNweekly News

IOC · Beijing

IOC finds Olympic sponsor in China through 2032 to replace Panasonic of Japan

48% Center coverage: 27 sources

See the Story

US Postal Service · Washington

Postal Service Responds to Postal Regulatory Commission's Advisory Opinion on Service Standard Changes

60% Center coverage: 20 sources

WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- The Postal Service today provided a pointed response to the Postal Regulatory Commission's (PRC) recently published Advisory Opinion on the organization's proposed service standard changes: PRC Docket No. N2024-1, captioned "Operational and Service Standards…See the Story

China · China

Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer

57% Center coverage: 19 sources

HONG KONG, Feb. 20, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in its multicenter, randomized, double-blind Phase III clinical trial of ivonescimab in combination with chemotherapy for…See the Story

News from TBNweekly

News from TBNweekly

Information about TBNweekly

Media Bias Ratings

Factuality

Ownership

Top TBNweekly News

IOC finds Olympic sponsor in China through 2032 to replace Panasonic of Japan

Postal Service Responds to Postal Regulatory Commission's Advisory Opinion on Service Standard Changes

Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer

Similar News Topics

Topics Most Covered by TBNweekly

Sources Covering Similar Topics

Breaking News Topics Related to TBNweekly

Ecopetrol Group replaced 104% of its production, doubling the 2023 incorporation of proven reserves.

FMC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FMC Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FMC (NYSE:FMC)

Studies: Tampa Bay still #1 in new residents

ZIONS BANCORPORATION TO PRESENT AT THE RBC CAPITAL MARKETS GLOBAL FINANCIAL INSTITUTIONS CONFERENCE

ROYAL CARIBBEAN GROUP INITIATES SHARE REPURCHASE ACTIVITY

New Medicus Healthcare Solutions White Paper Examines the U.S. Cardiologist Shortage

CNOOC Limited Brings On-stream Luda 5-2 North Oilfield Phase II Development Project

Boardable Expands Indiana Footprint; Announces Global Headquarters in Fishers